Gabriel Martínez-Botella

924 total citations
7 papers, 251 citations indexed

About

Gabriel Martínez-Botella is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Gabriel Martínez-Botella has authored 7 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Organic Chemistry and 1 paper in Infectious Diseases. Recurrent topics in Gabriel Martínez-Botella's work include Cancer therapeutics and mechanisms (3 papers), Biochemical and Molecular Research (2 papers) and Catalytic C–H Functionalization Methods (1 paper). Gabriel Martínez-Botella is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Biochemical and Molecular Research (2 papers) and Catalytic C–H Functionalization Methods (1 paper). Gabriel Martínez-Botella collaborates with scholars based in United States, United Kingdom and Australia. Gabriel Martínez-Botella's co-authors include François Maltais, Alex M. Aronov, Thomas A. Keating, Sameer Kawatkar, N.B. Olivier, James T. Loch, Christopher Baker, Jeremy Green, Michael Hale and Pamella J. Ford and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Journal of Neuroscience Research.

In The Last Decade

Gabriel Martínez-Botella

7 papers receiving 246 citations

Peers

Countries citing papers authored by Gabriel Martínez-Botella

Since Specialization

Citations

This map shows the geographic impact of Gabriel Martínez-Botella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Martínez-Botella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Martínez-Botella more than expected).

Fields of papers citing papers by Gabriel Martínez-Botella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Martínez-Botella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Martínez-Botella. The network helps show where Gabriel Martínez-Botella may publish in the future.

Co-authorship network of co-authors of Gabriel Martínez-Botella

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Martínez-Botella. A scholar is included among the top collaborators of Gabriel Martínez-Botella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Martínez-Botella. Gabriel Martínez-Botella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Discovery of the First Orally Available, Selective K_Na1.1 Inhibitor: In Vitro and In Vivo Activity of an Oxadiazole Series 2021 ·ACS Medicinal Chemistry Letters ·Andrew M. Griffin, Kristopher M. Kahlig, Robert J. Hatch, Zoë A. Hughes, Mark L. Chapman, Brett M. Antonio, Brian E. Marron, Marion Wittmann, Gabriel Martínez-Botella	24
2	Rescue of deficient amygdala tonic γ‐aminobutyric acidergic currents in theFmr^–/ymouse model of fragile X syndrome by a novel γ‐aminobutyric acid type A receptor‐positive allosteric modulator 2015 ·Journal of Neuroscience Research ·Brandon S. Martin, Gabriel Martínez-Botella, Carlos M. Loya, Francesco G. Salituro, Albert J. Robichaud, Molly M. Huntsman, (unknown), James Doherty, Jackie D. Corbin	8
3	Negishi cross-coupling enabled synthesis of novel NAD+-dependent DNA ligase inhibitors and SAR development 2015 ·Bioorganic & Medicinal Chemistry Letters ·Kerry E. Murphy-Benenato, Lakshmaiah Gingipalli, P. Ann Boriack‐Sjodin, Gabriel Martínez-Botella, (unknown), Charles J. Eyermann, (unknown), (unknown), Michael Hale, (unknown), (unknown), Michele Johnstone, Amy Kutschke, (unknown), James T. Loch, M.D. Miller, (unknown), (unknown)	9
4	Antibacterial Inhibitors of Gram-Positive Thymidylate Kinase: Structure–Activity Relationships and Chiral Preference of a New Hydrophobic Binding Region 2014 ·Journal of Medicinal Chemistry ·Sameer Kawatkar, Thomas A. Keating, N.B. Olivier, John Breen, (unknown), Satenig Guler, Martin Hentemann, James T. Loch, Andrew R. McKenzie, Joseph Newman, Linda G. Otterson, Gabriel Martínez-Botella	49
5	Structural Basis for Isoform Selectivity in a Class of Benzothiazole Inhibitors of Phosphoinositide 3-Kinase γ 2014 ·Journal of Medicinal Chemistry ·Philip N. Collier, Gabriel Martínez-Botella, Mark Cornebise, Kevin M. Cottrell, John Doran, James P. Griffith, Sudipta Mahajan, François Maltais, Cameron Stuver Moody, (unknown), Tiansheng Wang, Alex M. Aronov	39
6	Sulfonylpiperidines as novel, antibacterial inhibitors of Gram-positive thymidylate kinase (TMK) 2012 ·Bioorganic & Medicinal Chemistry Letters ·Gabriel Martínez-Botella, James T. Loch, (unknown), Sameer Kawatkar, N.B. Olivier, P. Ann Boriack‐Sjodin, Thomas A. Keating	24
7	Flipped Out: Structure-Guided Design of Selective Pyrazolylpyrrole ERK Inhibitors 2007 ·Journal of Medicinal Chemistry ·Alex M. Aronov, Christopher Baker, Guy W. Bemis, Jingrong Cao, Guanjing Chen, Pamella J. Ford, Ursula A. Germann, Jeremy Green, Michael Hale, Marc Jacobs, James W. Janetka, François Maltais, Gabriel Martínez-Botella, Mark Namchuk, (unknown), Qing Tang, Xiaoling Xie	98

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact